Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Geneviève Laforest"'
Autor:
Laurence Caron, Alexandre Fillion, Yves Giguère, François Audibert, Jean-Claude Forest, Cédric Gasse, Mario Girard, Geneviève Laforest, Paul Guerby, Emmanuel Bujold
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM).
Objectives Placental growth factor (PlGF) is used for first-trimester preeclampsia screening and could be combined with other biochemical markers for Down syndrome screening. We aim to estimate the predictive value of the combination of pregnancy-ass
Autor:
Paul Guerby, Alexandre Fillion, Suzanne Demers, Caroline Lachance, Marie-Claude Bussières, Geneviève Laforest, Emmanuel Bujold, Sophie Zérounian, Didier Menzies, Marie-Pier Comeau, Félicia-Allysson Doucet-Gingras
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 42:1235-1242
Objective Preeclampsia is associated with a higher maternal blood levels of soluble fms-like tyrosine kinase-1 (sFlt-1) and lower levels of placental growth factor (PlGF) that appear before clinical onset. We aimed to estimate the normal progression
Autor:
Amélie Tétu, Geneviève Laforest, Yves Giguère, Amélie Boutin, Cédric Gasse, Suzanne Demers, Emmanuel Bujold
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 40:1044-1049
Objective This study sought to estimate the ability of first trimester maternal serum placental growth factor (PlGF) to identify fetal aneuploidies. Methods A prospective cohort study of singleton pregnancy at 11 to 13 weeks was conducted. Maternal s
Autor:
Yves Giguère, Florence Roux-Dalvai, Jean-Claude Forest, Emmanuel Bujold, Geneviève Laforest, Arnaud Droit, Alexandre Fillion, Marie-Pier Scott-Boyer, Paul Guerby, Clarisse Gotti
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 20
Journal of Clinical Medicine, Vol 10, Iss 4679, p 4679 (2021)
Volume 10
Issue 20
Journal of Clinical Medicine, Vol 10, Iss 4679, p 4679 (2021)
Background: To explore the use of maternal urine proteome for the identification of preeclampsia biomarkers. Methods: Maternal urine samples from women with and without preeclampsia were used for protein discovery followed by a validation study. The
Autor:
Suzanne Demers, Emmanuel Bujold, Geneviève Laforest, Valérie Morin, Nydia Dorfeuille, Amélie Tétu, Bruno Piedboeuf, Katy Gouin
Publikováno v:
American Journal of Perinatology. 33:1003-1007
Objective The purpose of this study was to evaluate the predictive value of vaginal fluid biomarkers for chorioamnionitis and adverse perinatal outcomes in women with preterm premature rupture of membranes (PPROM). Methods We recruited women with PPR
Autor:
Amélie Boutin, Amélie Tétu, Geneviève Laforest, Yves Giguère, Suzanne Demers, Emmanuel Bujold, Cédric Gasse
Publikováno v:
Fetal diagnosis and therapy. 45(2)
Background: First-trimester maternal serum markers have been associated with preeclampsia (PE). We aimed to evaluate the performance of first-trimester placental growth factor (PlGF) for the prediction of PE in nulliparous women. Subjects and Methods
Autor:
Yves Giguère, Cédric Gasse, Suzanne Demers, Geneviève Laforest, Emmanuel Bujold, Amélie Boutin, Amélie Tétu
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 39:386
Autor:
Valérie Morin, Geneviève Laforest, Bruno Piedboeuf, Katy Gouin, Emmanuel Bujold, Nydia Dorfeuille, Amélie Tétu
Publikováno v:
American Journal of Obstetrics and Gynecology. 214:S290
Publikováno v:
Journal of applied toxicology : JAT. 28(2)
The safety of an ethylene oxide/propylene oxide gel formulation containing sodium lauryl sulfate (2%, w/w), that could be a potent candidate as a topical microbicide, has been evaluated. More specifically, the subchronic (26- and 52-week) toxicity of
Publikováno v:
American Journal of Obstetrics and Gynecology. 210:S15